LNSR
LENSAR Inc
NASDAQ: LNSR · HEALTHCARE · MEDICAL DEVICES
$5.23
-2.97% today
Updated 2026-04-30
Market cap
$63.02M
P/E ratio
—
P/S ratio
1.08x
EPS (TTM)
$-2.87
Dividend yield
—
52W range
$5 – $14
Volume
0.1M
LENSAR Inc (LNSR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $24.39M | $30.53M | $26.38M | $34.46M | $35.36M | $42.16M | $53.49M | $58.44M |
| Revenue growth (YoY) | — | +25.2% | -13.6% | +30.6% | +2.6% | +19.2% | +26.9% | +9.2% |
| Cost of revenue | $14.78M | $17.30M | $12.31M | $16.63M | $15.40M | $21.06M | $27.64M | $31.31M |
| Gross profit | $9.61M | $13.23M | $14.07M | $17.83M | $19.95M | $21.11M | $25.85M | $27.12M |
| Gross margin | 39.4% | 43.3% | 53.4% | 51.8% | 56.4% | 50.1% | 48.3% | 46.4% |
| R&D | $2.78M | $7.57M | $7.55M | $12.36M | $11.81M | $6.14M | $5.33M | $5.62M |
| SG&A | — | $17.15M | $23.77M | $23.89M | $27.17M | $26.93M | $26.49M | $45.16M |
| Operating income | $-9.32M | $-12.71M | $-18.50M | $-19.65M | $-20.18M | $-12.23M | $-10.66M | $-24.58M |
| Operating margin | -38.2% | -41.6% | -70.1% | -57.0% | -57.1% | -29.0% | -19.9% | -42.1% |
| EBITDA | $-4.66M | $-8.79M | $-15.36M | $-16.89M | $-16.77M | $-8.71M | $-3.00M | $-20.08M |
| EBITDA margin | -19.1% | -28.8% | -58.2% | -49.0% | -47.4% | -20.7% | -5.6% | -34.4% |
| EBIT | $-9.25M | $-12.66M | $-18.43M | $-19.65M | $-20.18M | $-12.23M | $-6.94M | $-24.58M |
| Interest expense | $0.00 | $2.00M | $1.34M | $1.19M | $263000.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-12.59M | $-14.66M | $-19.77M | $-19.60M | $-19.91M | $-14.38M | $-31.40M | $-34.28M |
| Net income growth (YoY) | — | -16.4% | -34.9% | +0.9% | -1.6% | +27.8% | -118.3% | -9.2% |
| Profit margin | -51.6% | -48.0% | -75.0% | -56.9% | -56.3% | -34.1% | -58.7% | -58.7% |